Findings

What do systematic reviews say?

10 questions · 13 findings · 4 reviews · Airways

No studies found 4 · 30.8%GRADE not reported 1 · 7.7%Very low 0 · 0%Low 2 · 15.4%Moderate 3 · 23.1%High 3 · 23.1%

Quality of life · bronchiectasis

1 finding from 1 review

Dual antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Quality of life · adults with bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

Head‐to‐head trials of antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Quality of life · adults aged 18 years and above with diagnosis of non‐cystic fibrosis bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

Head‐to‐head trials of antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Quality of life: change · adults with bronchiectasis

1 finding from 1 review

Macrolide antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 305 participants
Low

Quality of life: 1a. Average endpoint scores on various scales (MSQoL‐54, high = good) ‐ short term · adults with bronchiectasis

1 finding from 1 review

Macrolide antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 68 participants
Moderate

Quality of life not reported · children with bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

Macrolide antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Health‐related quality of life · people with bronchiectasis

2 findings from 1 review

Intermittent prophylactic antibiotics for bronchiectasis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Moderate
Intermittent prophylactic antibiotics for bronchiectasis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Health‐related quality of life · people with bronchiectasis

2 findings from 1 review

Intermittent prophylactic antibiotics for bronchiectasis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
High
Intermittent prophylactic antibiotics for bronchiectasis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
High

Health‐related quality of life · people with bronchiectasis

2 findings from 1 review

Intermittent prophylactic antibiotics for bronchiectasis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
High
Intermittent prophylactic antibiotics for bronchiectasis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Moderate

Quality of life ‐ not reported · children with bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

Macrolide antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found